WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy L. BurroughsChief Executive Officer2026-01-1561,228$37.02
$2.27MSell
Amy L. BurroughsChief Executive Officer2026-01-157,521$37.53
$282.23kSell
Amy L. BurroughsChief Executive Officer2026-01-1527,083$4.64
$125.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-1527,083$4.64
$125.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-1514,583$4.64
$67.67kBuy
Amy L. BurroughsChief Executive Officer2026-01-0571,339$38.10
$2.72MSell
Emil KuriakoseChief Medical Officer2026-01-02955$38.36
$36.63kSell
Amy L. BurroughsChief Executive Officer2026-01-0221,551$4.64
$100.00kBuy
Emil KuriakoseChief Medical Officer2026-01-02200$39.60
$7.92kSell
Jill M. QuigleyDirector2025-11-0424,520$9.24
$226.56kBuy

1 of 2

TERN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC12.81%11,536,701$404.82MInsider
Soleus Capital Management LP9.02%8,127,100$285.18MInstitution
Morgan Stanley8.42%7,589,095$266.30MInstitution
Orbimed Advisors LLC8.40%7,562,971$265.38MInstitution
Deep Track Capital LP8.32%7,495,000$263.00MInstitution
Vivo Capital LLC7.66%6,895,746$241.97MInstitution
Commodore Capital LP6.33%5,700,000$200.01MInstitution
Blackrock Inc6.16%5,551,308$194.80MInstitution
Vanguard Group Inc5.06%4,559,917$160.01MInstitution
Adage Capital Partners GP LLC4.37%3,939,000$138.22MInstitution

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN81.05%18.95%Net SellingNet Selling
DNLI60.44%39.56%Net SellingNet Selling
ARQT76.71%23.29%Net SellingNet Selling
VCYT67.83%32.17%Net SellingNet Selling
EWTX87.72%12.28%Net BuyingNet Buying
View Top Biotech Stocks

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 98.39% institutional shareholders, 23.00% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.54M shares representing 12.81% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $395.25M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.